Fundraising Fox

Florian Müellershausen

Investor

Managing Director at Novartis Venture Fund

Basel, Switzerland

About

Florian Muellershausen, PhD, is a Managing Director at the Novartis Venture Fund. Before joining NVF, he served as a Scientific Manager for the R&D Committee of the Novartis Board of Directors and previously held drug discovery roles in Novartis R&D, including Laboratory Head in target discovery and Translational Medicine Expert in autoimmunity within early clinical research. He holds an MSc in Biochemistry from Free University Berlin, a PhD in Biochemistry from Ruhr University Bochum, and completed postdoctoral training at Novartis in Switzerland.

Contact· self-published, not guessed

Invests in

Biotech

Investments

Board seats

AnaveonCitryllLoQus23 TherapeuticsONL TherapeuticsRhyGazeSalvinaSpliceBio

Per the firm's website.

Colleagues at Novartis Venture Fund

Frequently asked questions

Who is Florian Müellershausen?
Florian Muellershausen, PhD, is a Managing Director at the Novartis Venture Fund. Before joining NVF, he served as a Scientific Manager for the R&D Committee of the Novartis Board of Directors and previously held drug discovery roles in Novartis R&D, including Laboratory Head in target discovery and Translational Medicine Expert in autoimmunity within early clinical research. He holds an MSc in Biochemistry from Free University Berlin, a PhD in Biochemistry from Ruhr University Bochum, and completed postdoctoral training at Novartis in Switzerland.
Where does Florian Müellershausen work?
Florian Müellershausen is Managing Director at Novartis Venture Fund.
What does Florian Müellershausen invest in?
Florian Müellershausen invests in Biotech.
What boards does Florian Müellershausen sit on?
Florian Müellershausen holds tracked board seats at Anaveon, Citryll, LoQus23 Therapeutics, ONL Therapeutics, RhyGaze, Salvina, SpliceBio.